美国疾病控制与预防中心从网站上删除一些关于羟氯喹的信息

2020年4月12日08:48:37新闻美国疾病控制与预防中心从网站上删除一些关于羟氯喹的信息已关闭评论991字数 3037阅读10分7秒阅读模式

美国疾病控制与预防中心从网站上删除一些关于羟氯喹的信息A federal health agency removed several paragraphs of information about hydroxychloroquine from its website,including recommended dosing information.

一个联邦健康机构从其网站上删除了几段关于羟氯喹的信息,包括推荐剂量信息。

Hydroxychloroquine,a drug used to treat malaria and lupus,has shown promising results in early trials against COVID-19,the disease caused by the CCP(Chinese Communist Party)virus,commonly known as the novel coronavirus.

羟氯喹,一种用于治疗疟疾和红斑狼疮的药物,在针对新型冠状病毒肺炎的早期试验中显示出有希望的结果,红斑狼疮是由中共病毒引起的疾病,俗称新型冠状病毒。

The Centers for Disease Control and Prevention(CDC)said last month that hydroxychloroquine was being used in hospitals to treat COVID-19 patients.It later added information about dosing,based on recommendations from some clinicians.

美国疾病控制和预防中心上个月表示,羟氯喹已经被医院用于治疗新型冠状病毒肺炎患者。后来根据一些临床医生的建议增加了剂量的信息。

"Although optimal dosing and duration of hydroxychloroquine for treatment of COVID-19 are unknown,some U.S.clinicians have reported anecdotally different hydroxychloroquine dosing such as:400mg BID on day one,then daily for 5 days;400 mg BID on day one,then 200mg BID for 4 days;600 mg BID on day one,then 400mg daily on days 2-5,"it stated.

"尽管羟氯喹治疗新型冠状病毒肺炎的最佳剂量和持续时间尚不清楚,但一些美国临床医生有趣地报告了不同的羟氯喹剂量,比如:第一天400毫克 BID,然后连续5天每天400毫克 BID;第一天400毫克 BID,然后连续4200毫克 BID;第一天600毫克 BID,第二天至第五天400毫克 BID"

Four paragraphs of information about hydroxychloroquine and the closely related drug chloroquine were included by the agency.Three of those paragraphs were removed on April 7,including the information about dosing.The agency cut 409 words to 56.

关于羟氯喹和与之密切相关的药物氯喹的4段信息被该机构收录。其中三个段落在47日被删除,包括关于剂量的信息。该机构将409个单词减少到56个。

The archived page showing the old page is here and the updated webpage is here.

显示旧页面的存档页面在这里,更新的网页在这里。

The CDC didn't immediately respond to a request for comment.

疾病预防控制中心没有立即回复记者的置评请求。

Several paragraphs about remdesivir,an experimental drug also being explored for use against COVID-19,were also removed.

几段关于雷德斯韦的文章也被删除了,雷德斯韦是一种试验性药物,也正在研究用于治疗新型冠状病毒肺炎。

Hydroxychloroquine is being prescribed across the nation,according to doctors,and a number of stories have emerged attesting to its alleged efficacy,including a lawmaker in Michigan.On the other hand,some medical professionals have said there isn't enough proof to attribute the recovery of some patients to the drug,cautioning people to wait until clinical trials are finished.

根据医生的说法,羟氯喹正在全国范围内被开出,并且已经出现了许多故事来证明它的所谓功效,包括密歇根州的一位立法者。另一方面,一些医学专家表示,没有足够的证据证明一些病人的康复与该药有关,他们提醒人们等到临床试验结束再说。

Worldwide movement on the drug includes India banning its export and advising healthcare workers to take it as a prophylactic;Hungary banning its export;and Bahrain saying it has proven effective.Doctors across 30 nations rated the drug as the most effective treatment against COVID-19.

世界范围内禁止该药物的运动包括印度禁止该药物的出口,并建议医疗工作者将其作为预防药物;匈牙利禁止该药物的出口;巴林则表示该药物已被证明有效。来自30个国家的医生认为这种药物是对抗新型冠状病毒肺炎最有效的治疗方法。

The United States obtained 29 million doses of hydroxychloroquine and the Food and Drug Administration issued an emergency use authorization for the drug and chloroquine for treatment of COVID-19 patients in hospitals.

美国获得了2900万剂羟氯喹,美国食品和药物管理局发布了这种药物和氯喹的紧急使用授权,用于在医院治疗新型冠状病毒肺炎患者。

The updated CDC page points people to the administration's authorization as well as a website that contains information about clinical trials.

更新的 CDC 页面将人们引向了管理部门的授权以及一个包含临床试验信息的网站。

来源:https://www.theepochtimes.com/cdc-removes-some-information-about-hydroxychloroquine-from-website_3303664.html

zhunbeizhuanbian
  • 本文由 发表于 2020年4月12日08:48:37
  • 除非特殊声明,本站文章均来自网络,转载请务必保留本文链接